Abbott to Expand US Manufacturing as Tariff Impact Looms (3)

April 16, 2025, 1:39 PM UTC

Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry.

It expects to spend $500 million on two facilities, located in Illinois and Texas, Abbott said in a statement Wednesday. The investments are to expand existing plants and boost US research and development for Abbott’s transfusion business, which is responsible for screening the US blood supply.

The company will hire as many as 200 people in Illinois and as many as 100 people in Texas to support the work, a spokesperson said.

Shares rose as much as ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.